Life Sciences Counsel Quoted in FDA WeekExplaining Proposed New Model for Regulation of Drug Promotion
Life sciences counsel Alan Bennett
(of Washington, D.C.) co-authored, along with Johnson & Johnson’s Assistant General Counsel Freddie Jimenez and Janssen Pharmaceuticals Senior Director of Clinical Development Larry Fields, an article proposing a new model for the regulation of drug promotion published by The Journal of Law and the Biosciences
on March 20. An FDA Week
article published on July 2 features extensive excerpts from the The Journal of Law and the Biosciences
piece, and quotes Mr. Bennett offering perspectives on why regulations governing the promotion of drugs need to be re-worked.